77 related articles for article (PubMed ID: 36315303)
1. Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition.
Zhou M; Liu C; Li B; Li J; Zhang P; Huang Y; Li L
Nat Commun; 2024 Mar; 15(1):2763. PubMed ID: 38553476
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral CXCR4
Lu Z; Wang X; Feng J; Chai W; Wang W; Wang Q; Yang S; Yang W; Su Y; Mou W; Peng Y; Wang H; Gui J
Front Immunol; 2024; 15():1363454. PubMed ID: 38487536
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression.
Dalle Carbonare L; Minoia A; Vareschi A; Piritore FC; Zouari S; Gandini A; Meneghel M; Elia R; Lorenzi P; Antoniazzi F; Pessoa J; Zipeto D; Romanelli MG; Guardavaccaro D; Valenti MT
Cells; 2024 Feb; 13(5):. PubMed ID: 38474372
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma.
Fang J; Singh S; Cheng C; Natarajan S; Sheppard H; Abu-Zaid A; Durbin AD; Lee HW; Wu Q; Steele J; Connelly JP; Jin H; Chen W; Fan Y; Pruett-Miller SM; Rehg JE; Koo SC; Santiago T; Emmons J; Cairo S; Wang R; Glazer ES; Murphy AJ; Chen T; Davidoff AM; Armengol C; Easton J; Chen X; Yang J
Nat Commun; 2023 Jul; 14(1):4003. PubMed ID: 37414763
[TBL] [Abstract][Full Text] [Related]
5. KLF8 promotes invasive outgrowth of breast cancer by inducing filopodium-like protrusions via CXCR4.
Mukherjee D; Hao J; Lu H; Lahiri SK; Yu L; Zhao J
Am J Transl Res; 2022; 14(2):1220-1233. PubMed ID: 35273724
[TBL] [Abstract][Full Text] [Related]
6. Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3.
Galal KA; Krämer A; Strickland BG; Smith JL; Dickmander RJ; Moorman NJ; Willson TM
Bioorg Med Chem Lett; 2024 Feb; 99():129617. PubMed ID: 38199328
[TBL] [Abstract][Full Text] [Related]
7. Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3.
Galal KA; Krämer A; Strickland BG; Smith JL; Dickmander RJ; Moorman NJ; Willson TM
bioRxiv; 2023 Dec; ():. PubMed ID: 38106118
[TBL] [Abstract][Full Text] [Related]
8. Commentary on the challenges of modeling hepatoblastoma in-vivo.
Hurley EH
Pediatr Res; 2024 Apr; ():. PubMed ID: 38649725
[No Abstract] [Full Text] [Related]
9. The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on Hepatoblastoma.
Bownes LV; Julson JR; Quinn CH; Hutchins SC; Erwin MH; Markert HR; Stewart JE; Mroczek-Musulman E; Aye J; Yoon KJ; Ohlmeyer M; Beierle EA
J Pediatr Surg; 2023 Jun; 58(6):1145-1154. PubMed ID: 36907775
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype.
Julson JR; Quinn CH; Bownes LV; Hutchins SC; Stewart JE; Aye J; Yoon KJ; Beierle EA
J Pediatr Surg; 2023 Jun; 58(6):1155-1163. PubMed ID: 36907773
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of
Zheng X; Zhao X; Wang Y; Chen J; Wang X; Peng X; Ma L; Du J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628919
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.
Marayati R; Stafman LL; Williams AP; Bownes LV; Quinn CH; Markert HR; Easlick JL; Stewart JE; Crossman DK; Mroczek-Musulman E; Beierle EA
Cancer Gene Ther; 2022 May; 29(5):558-572. PubMed ID: 33864024
[TBL] [Abstract][Full Text] [Related]
13. The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.
Stafman LL; Waldrop MG; Williams AP; Aye JM; Stewart JE; Mroczek-Musulman E; Yoon KJ; Whelan K; Beierle EA
J Pediatr Surg; 2019 Jun; 54(6):1206-1213. PubMed ID: 30898394
[TBL] [Abstract][Full Text] [Related]
14. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
15. CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3.
Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L
Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563
[No Abstract] [Full Text] [Related]
16. PIM3 Kinase: A Promising Novel Target in Solid Cancers.
Atalay P; Ozpolat B
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339286
[TBL] [Abstract][Full Text] [Related]
17. PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.
Marayati R; Julson J; Bownes LV; Quinn CH; Stafman LL; Beierle AM; Markert HR; Hutchins SC; Stewart JE; Crossman DK; Hjelmeland AB; Mroczek-Musulman E; Beierle EA
Clin Exp Metastasis; 2022 Dec; 39(6):899-912. PubMed ID: 36315303
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
